A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19.
Xie X, Muruato AE, Zhang X, Lokugamage KG, Fontes-Garfias CR, Zou J, Liu J, Ren P, Balakrishnan M, Cihlar T, Tseng CK, Makino S, Menachery VD, Bilello JP, Shi PY.
Xie X, et al. Among authors: makino s.
Nat Commun. 2020 Oct 15;11(1):5214. doi: 10.1038/s41467-020-19055-7.
Nat Commun. 2020.
PMID: 33060595
Free PMC article.